15 wyniki
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. national phase application filed under 35 USC .sctn. 371 of International Application No. PCT/EP2014/066299, which was filed Jul. 29, 2014, and which claims the benefit of the filing date of EP Application No. 13003776.5, which was
FIELD OF THE INVENTION
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch (HES) and glycerol or DMSO together
TECHNICAL FIELD
The present invention relates to a starch composition containing a high proportion of so-called "resistant starch" (RS). The composition of the resistant starch is further characterised by a specific chain length distribution of the RS-fraction and by a relatively low specific
BACKGROUND OF THE INVENTION
The present invention is concerned with the use of starch containing amylose as a complexant with iodine for preparing dry powder pharmaceutical formulations useful in the preparation of capsules or tablets.
More particularly, the invention is concerned with the
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising Lipiodol and a molecule with anti-tumour activity and secondarily a hydroxyethyl starch. The present invention also relates to the use of the compositions according to the invention for treating
This application is a 371 of PCT/DE98/01514 Jun. 4, 1998.
BACKGROUND OF THE INVENTION
The invention relates to a new anti-tumoral therapy agent based on liposome-encapsulated cytostatic agents and/or the metabolites thereof. Fields of application of the invention are pharmaceutical industry and
The present invention relates to a method for treating human subjects to prevent leakage of macromolecules from capillary endothelial junctions as a consequence of extremely severe and life threatening side effects due to cancer biological therapy for cancer, infectious diseases, septic shock, and
FIELD OF THE INVENTION
This invention relates to the synthesis of macromolecular prodrugs of nucleotide analogs and their uses as antiviral and anticancer agents.
BACKGROUND
Nucleoside analogs are a class of compounds that have been shown to exert antiviral and antitumor activity both in vitro and
This application claims benefit of international application PCT/GB94/00713, filed Nov. 17, 1994, published as WO95/13801 May 26, 1995.
FIELD OF THE INVENTION
This invention relates to an agent for use in food, dietary, and the like preparations, and to preparations, formulations and dietary
FIELD OF THE INVENTION
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch (HES) and glycerol or DMSO together
BACKGROUND OF THE INVENTION
1.0 Field of the Invention
The invention relates to compositions and methods for the cryopreservation of cellular vaccines. More specifically, the invention relates to the use of particular compositions comprising cryoprotective media that includes hydroxyethyl starch
The present invention is concerned with the use of starch containing amylose as a complexant with iodine for preparing dry powder pharmaceutical formulations useful in the preparation of capsules or tablets. More particularly, the invention is concerned with the administration of molecular iodine
FIELD OF INVENTION
This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure.
BACKGROUND
Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence
FIELD OF INVENTION
The invention relates to a composition for the treatment of tumors, its production and its use and, in particular, for the treatment of non-resectable primary and metastasized liver tumors.
BACKGROUND
In anti-tumor therapy of non-resectable liver tumors, the regional
The following examples illustrate the present invention, but it is to be understood that they are given for the purpose of illustration and not limitation.
EXAMPLE 1
A medium (100 l) containing 6.0% soluble starch, 4.0% cotton seed meal, 0.2% (NH.sub.4).sub.2 SO.sub.4, 0.1% yeast extract, 0.2%